Cargando…
Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011645/ https://www.ncbi.nlm.nih.gov/pubmed/36925634 http://dx.doi.org/10.3389/fphar.2023.1164723 |
_version_ | 1784906442133733376 |
---|---|
author | Giuliani, Anna Lisa Bortoluzzi, Alessandra Oliviero, Francesca |
author_facet | Giuliani, Anna Lisa Bortoluzzi, Alessandra Oliviero, Francesca |
author_sort | Giuliani, Anna Lisa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10011645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100116452023-03-15 Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II Giuliani, Anna Lisa Bortoluzzi, Alessandra Oliviero, Francesca Front Pharmacol Pharmacology Frontiers Media S.A. 2023-02-28 /pmc/articles/PMC10011645/ /pubmed/36925634 http://dx.doi.org/10.3389/fphar.2023.1164723 Text en Copyright © 2023 Giuliani, Bortoluzzi and Oliviero. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Giuliani, Anna Lisa Bortoluzzi, Alessandra Oliviero, Francesca Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title | Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title_full | Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title_fullStr | Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title_full_unstemmed | Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title_short | Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II |
title_sort | editorial: autoimmune and inflammatory rheumatic diseases: identifying biomarkers of response to therapy with biologics: volume ii |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011645/ https://www.ncbi.nlm.nih.gov/pubmed/36925634 http://dx.doi.org/10.3389/fphar.2023.1164723 |
work_keys_str_mv | AT giulianiannalisa editorialautoimmuneandinflammatoryrheumaticdiseasesidentifyingbiomarkersofresponsetotherapywithbiologicsvolumeii AT bortoluzzialessandra editorialautoimmuneandinflammatoryrheumaticdiseasesidentifyingbiomarkersofresponsetotherapywithbiologicsvolumeii AT olivierofrancesca editorialautoimmuneandinflammatoryrheumaticdiseasesidentifyingbiomarkersofresponsetotherapywithbiologicsvolumeii |